Drugs Made In America Acquisition II
DMIINasdaq United StatesFinanceBlank Checks
Market cap
$651.014 M
$10.22 -0.10%
Close of 6 Nov 2026
As of 6 Nov 2026, Drugs Made In America Acquisition II (DMII) has a market capitalization of $651.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
$4.19M
#2201 by earnings
Shares outstanding
63,700,000
Latest filing cover page
P/E ratio
155.5
Cap ÷ net income
Other share classes
Drugs Made In America Acquisition II lists more than one class of stock. Company figures above cover all classes combined.
Blank Checks, ranked by market cap
All 41 →- #1Drugs Made In America Acquisition IIDMII$651.0M
- #2Idea AcquisitionIACO$437.5M
- #3Berto Acquisition Corp. IIGUAC$389.1M
- #4Berto AcquisitionTACO$382.6M
- #5Iron Horse Acquisition IIIRHO$295.3M
What if Drugs Made In America Acquisition II were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Drugs Made In America Acquisition II are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.